D. Vanjak

766 total citations
14 papers, 489 citations indexed

About

D. Vanjak is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, D. Vanjak has authored 14 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Infectious Diseases and 6 papers in Molecular Medicine. Recurrent topics in D. Vanjak's work include Antibiotic Resistance in Bacteria (6 papers), Antibiotic Use and Resistance (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). D. Vanjak is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Antibiotic Use and Resistance (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). D. Vanjak collaborates with scholars based in France, Switzerland and Greece. D. Vanjak's co-authors include Jean Christophe Lucet, B. Régnier, M Wolff, Dominique Decré, Sylvie Chevret, Jean Pierre Bedos, Jean‐Christophe Lucet, Jean‐François Timsit, Cathérine Paugam‐Burtz and Najiby Kassis and has published in prestigious journals such as Clinical Infectious Diseases, Vaccine and Infection Control and Hospital Epidemiology.

In The Last Decade

D. Vanjak

14 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Vanjak France	9	291	194	161	125	115	14	489
N Singh United States	5	422 1.5×	253 1.3×	255 1.6×	88 0.7×	190 1.7×	7	721
V Ramasubramanian India	15	292 1.0×	266 1.4×	304 1.9×	90 0.7×	213 1.9×	48	707
Nadim G. El Chakhtoura United States	8	255 0.9×	107 0.6×	92 0.6×	112 0.9×	56 0.5×	13	444
Dania Abdallah Lebanon	11	188 0.6×	136 0.7×	144 0.9×	53 0.4×	94 0.8×	29	438
Rujipas Sirijatuphat Thailand	10	266 0.9×	187 1.0×	118 0.7×	177 1.4×	260 2.3×	34	651
Satyajit Mohapatra India	6	273 0.9×	135 0.7×	108 0.7×	111 0.9×	68 0.6×	29	459
Monica V. Mahoney United States	14	187 0.6×	272 1.4×	150 0.9×	176 1.4×	157 1.4×	43	590
Jung-Jr Ye Taiwan	15	206 0.7×	170 0.9×	106 0.7×	92 0.7×	155 1.3×	28	495
Emese Szilágyi Hungary	11	195 0.7×	109 0.6×	138 0.9×	46 0.4×	107 0.9×	13	420
Thomas Man-kit So Thailand	6	292 1.0×	432 2.2×	116 0.7×	120 1.0×	76 0.7×	8	691

Countries citing papers authored by D. Vanjak

Since Specialization

Citations

This map shows the geographic impact of D. Vanjak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Vanjak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Vanjak more than expected).

Fields of papers citing papers by D. Vanjak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Vanjak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Vanjak. The network helps show where D. Vanjak may publish in the future.

Co-authorship network of co-authors of D. Vanjak

This figure shows the co-authorship network connecting the top 25 collaborators of D. Vanjak. A scholar is included among the top collaborators of D. Vanjak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Vanjak. D. Vanjak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Khanafer, Nagham, Benoît Guéry, Anne Vachée, et al.. (2021). Establishment of a French surveillance system of Clostridiodes difficile infection: Comparison of patient’s characteristics with other national and European data. Anaerobe. 69. 102329–102329. 1 indexed citations

Frélaut, Maxime, Perrine Vuagnat, Laurence Bozec, et al.. (2021). Première vague COVID-19 : expérience d’un centre de lutte contre le cancer. Bulletin du Cancer. 108(6). 571–580. 1 indexed citations

Vanjak, D., et al.. (2017). Practices of infectious control management during neutropenia: A survey from 149 French hospitals. Journal de Mycologie Médicale. 27(2). 227–231. 2 indexed citations

Longuet, P., Rui Batista, R. Gauzit, et al.. (2016). Preparing and administering injectable antibiotics: How to avoid playing God. Médecine et Maladies Infectieuses. 46(5). 242–268. 31 indexed citations

Lepeule, R., Véronique Leflon‐Guibout, D. Vanjak, et al.. (2014). Clinical spectrum of urine cultures positive for ESBL-producing Escherichia coli in hospitalized patients and impact on antibiotic use. Médecine et Maladies Infectieuses. 44(11-12). 530–534. 12 indexed citations

Fournier, S., Florence Brossier, Nicolas Fortineau, et al.. (2012). Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience. Eurosurveillance. 17(30). 27 indexed citations

Vanjak, D., Irène Kriegel, Jens Otto, et al.. (2010). Acceptance of the 2009 A(H1N1) influenza vaccine among hospital workers in two French cancer centers. Vaccine. 28(43). 7030–7034. 51 indexed citations

Vanjak, D., et al.. (2009). [Influenza and other viral diseases, historical reminders of large pandemics].. PubMed. 32–5. 1 indexed citations

Vanjak, D., et al.. (2007). Risk Factors forClostridium difficileInfection in a Hepatology Ward. Infection Control and Hospital Epidemiology. 28(2). 202–204. 17 indexed citations

10.

Vanjak, D., et al.. (2006). Cas de coqueluche parmi le personnel d'un service de maternité : gestion d'une alerte sanitaire. Médecine et Maladies Infectieuses. 36(3). 151–156. 9 indexed citations

11.

Paramythiotou, Elisabeth, Jean‐Christophe Lucet, Jean‐François Timsit, et al.. (2004). Acquisition of Multidrug‐ResistantPseudomonas aeruginosain Patients in Intensive Care Units: Role of Antibiotics with Antipseudomonal Activity. Clinical Infectious Diseases. 38(5). 670–677. 147 indexed citations

12.

Lucet, Jean Christophe, Sylvie Chevret, Dominique Decré, et al.. (1996). Outbreak of Multiply Resistant Enterobacteriaceae in an Intensive Care Unit: Epidemiology and Risk Factors for Acquisition. Clinical Infectious Diseases. 22(3). 430–436. 167 indexed citations

13.

Vanjak, D., Claudette Muller‐Serieys, Bertrand Picard, E Bergogne-Bérézin, & N Lambert-Zechovsky. (1995). Activity of beta-lactamase inhibitor combinations onEscherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents. European Journal of Clinical Microbiology & Infectious Diseases. 14(11). 972–978. 16 indexed citations

14.

Millaire, A, O. Leroy, C. Beuscart, et al.. (1990). [Infectious endocarditis of the tricuspid valve in patients with endocardial pacemakers].. PubMed. 83(12). 1855–7. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact